"Adenosine Deaminase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA.
| Descriptor ID |
D000243
|
| MeSH Number(s) |
D08.811.277.151.486.075
|
| Concept/Terms |
Adenosine Deaminase- Adenosine Deaminase
- Deaminase, Adenosine
- Adenosine Aminohydrolase
- Aminohydrolase, Adenosine
|
Below are MeSH descriptors whose meaning is more general than "Adenosine Deaminase".
Below are MeSH descriptors whose meaning is more specific than "Adenosine Deaminase".
This graph shows the total number of publications written about "Adenosine Deaminase" by people in this website by year, and whether "Adenosine Deaminase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 |
| 2017 | 10 | 1 | 11 |
| 2018 | 9 | 2 | 11 |
| 2019 | 2 | 3 | 5 |
| 2020 | 3 | 0 | 3 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Adenosine Deaminase" by people in Profiles.
-
Analytical validation of an automated assay for the measurement of adenosine deaminase (ADA) and its isoenzymes in saliva and a pilot evaluation of their changes in patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2021 Aug 26; 59(9):1592-1599.
-
The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection. Clin Immunol. 2021 05; 226:108699.
-
Host-directed editing of the SARS-CoV-2 genome. Biochem Biophys Res Commun. 2021 01 29; 538:35-39.
-
Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses. Sci Rep. 2020 10 20; 10(1):17766.
-
Ocular Surface Expression of SARS-CoV-2 Receptors. Ocul Immunol Inflamm. 2020 Jul 03; 28(5):735-738.
-
Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2. Sci Adv. 2020 06; 6(25):eabb5813.
-
ADAR1 promotes HBV replication through its deaminase domain. Front Biosci (Landmark Ed). 2020 01 01; 25(4):710-721.
-
A monogenic autoinflammatory disease with fatal vasculitis: deficiency of adenosine deaminase 2. Curr Opin Rheumatol. 2020 01; 32(1):3-14.
-
Clinical characteristics and potential indicators for definite diagnosis of tuberculous pleural effusion. Artif Cells Nanomed Biotechnol. 2019 Dec; 47(1):1924-1931.
-
ADAR1: "Editor-in-Chief" of Cytoplasmic Innate Immunity. Front Immunol. 2019; 10:1763.